Parkman Healthcare Partners’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.11M | Buy |
73,412
+9,472
| +15% | +$272K | 0.24% | 80 |
|
|
2025
Q1 | $2.14M | Buy |
63,940
+12,807
| +25% | +$430K | 0.25% | 74 |
|
|
2024
Q4 | $2.61M | Sell |
51,133
-26,490
| -34% | -$1.35M | 0.35% | 64 |
|
|
2024
Q3 | $3.97M | Sell |
77,623
-63,752
| -45% | -$3.26M | 0.51% | 59 |
|
|
2024
Q2 | $6.33M | Buy |
141,375
+40,256
| +40% | +$1.8M | 0.85% | 40 |
|
|
2024
Q1 | $4.73M | Sell |
101,119
-19,533
| -16% | -$914K | 0.58% | 58 |
|
|
2023
Q4 | $4.29M | Buy |
120,652
+20,652
| +21% | +$735K | 0.6% | 53 |
|
|
2023
Q3 | $2.97M | Buy |
+100,000
| New | +$2.97M | 0.54% | 54 |
|